InvestorsHub Logo
Followers 0
Posts 29
Boards Moderated 0
Alias Born 05/07/2019

Re: None

Wednesday, 04/01/2020 3:33:42 AM

Wednesday, April 01, 2020 3:33:42 AM

Post# of 8441
BIG Breakout!!!!!


NVAX
Emergent BioSolutions Inc. has inked another deal with fellow Gaithersburg biotech Novavax Inc. — this time, for its seasonal flu vaccine.

The agreement means Emergent (NYSE: EBS) will develop and manufacture NanoFlu, the influenza vaccine which Novavax (NASDAQ: NVAX) successfully pushed through phase 3 clinical trials in a critical win announced March 24. It also comes just a few weeks after the two companies teamed up to get a COVID-19 vaccine to the clinic in the race against the pandemic.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News